Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

ASSOCIATION OF ACCESSIBLE MEDICINES

Filed by MEHLMAN CONSULTING, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2025
Income
$60,000.00
Expenses
Not reported
Filing UUID
eaec4aba-09b5-4ed3-ad57-3922f1d5054c
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Issues related to generic medicines.

HCR · Health Issues

Issues related to generic medicines. issues related to generic and biosimilar medications.

PHA · Pharmacy

Issues related to pharmaceutical manufacturing supply chain. S. 1040 - Drug Competition Enhancement Act. S. 1954 - Biosimilar Red Tape Elimination Act. H.R. 3269 - ETHIC Act.

Literal federal measure citations: S. 1040, S. 1954, H.R. 3269

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.